Te­va tem­porar­i­ly pad­locks a plant af­ter FDA cites it for con­t­a­m­i­na­tion

Af­ter FDA in­ves­ti­ga­tors un­veiled a list of prob­lems that were found at a Te­va Phar­ma­ceu­ti­cals plant in Irvine, CA, in­clud­ing mold stem­ming from wa­ter leaks, the com­pa­ny said it will halt pro­duc­tion at that site un­til it is able to meet qual­i­ty ex­pec­ta­tions.

A Te­va spokesper­son con­firmed the tem­po­rary man­u­fac­tur­ing stop­page Mon­day morn­ing in an email to End­points News, say­ing that that pro­duc­tion will re­sume af­ter a re­view is con­duct­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER